Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 30 March, 2020

Societe Generale SA

Form 8.3 - Allergan plc

RNS Number : 0165I
Societe Generale SA
30 March 2020
 

  Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

Société Générale S.A.

Companydealtin

   Allergan plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.0001 ordinary shares

Date of dealing

27/03/2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

1,806,485

0.55

52,073

0.02

(2) Derivatives (other than options)

0

0.00

1,385,296

0.42

(3) Options and agreements to purchase/sell

58,500

0.02

0

0.00

Total

*5,342,238

*1.62

1,437,369

0.44

 

* Include the holding of 3,477,253 shares on borrow products

 

 

 

(b)  Interests and short positions in relevant securities of the company, other than the class dealt in  (Note   3)

Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities

 

 

 

 

(2) Derivatives (other than options)

 

 

 

 

(3) Options and agreements to purchase/sell

 

 

 

 

Total

 

 

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit USD (Note 5)

Purchase

100

175.1

Purchase

100

175.07

Purchase

83

174.97

Purchase

100

175.46

Purchase

100

175.39

Purchase

100

174.61

Purchase

100

174.53

Purchase

50

174.61

Purchase

50

174.61

Purchase

100

175.37

Purchase

7

175.52

Purchase

54

175.63

Purchase

46

175.63

Purchase

18

174.52

Purchase

50

175.04

Purchase

100

174.9

Purchase

36

175.21

Purchase

100

172.49

Purchase

14

174.92

Purchase

100

174.53

Purchase

50

175.98

Purchase

100

176.02

Purchase

40

175.98

Purchase

10

175.98

Purchase

100

175.99

Purchase

17

174.97

Purchase

100

175.48

Purchase

82

174.52

Purchase

100

174.69

Purchase

100

174.69

Purchase

100

175.08

Purchase

100

175.9

Purchase

100

175.89

Purchase

50

175.12

Purchase

100

173.33

Purchase

100

175.37

Purchase

100

175.37

Purchase

100

174.72

Purchase

50

175.12

Purchase

100

175.3

Purchase

100

174.21

Purchase

100

173.31

Purchase

100

175.09

Purchase

100

175.06

Purchase

100

174.54

Purchase

100

174.57

Purchase

100

174.56

Purchase

100

174.48

Purchase

100

176.1

Purchase

7

174.25

Purchase

100

176.23

Purchase

5

174.78

Purchase

95

174.78

Purchase

100

175.92

Purchase

100

175.94

Purchase

13

176.18

Purchase

87

176.18

Purchase

100

176.07

Purchase

100

174.34

Purchase

16

174.83

Purchase

100

174.35

Purchase

100

175.07

Purchase

15

174.87

Purchase

84

174.87

Purchase

100

174.32

Purchase

100

175.4

Purchase

100

174.6

Purchase

100

174.62

Purchase

1

174.87

Purchase

100

174.76

Purchase

100

174.58

Purchase

47

173.44

Purchase

400

174.6425

Purchase

122

173.08

Purchase

100

174.72

Purchase

100

174.79

Purchase

100

173.17

Purchase

100

174.42

Purchase

66

172.46

Purchase

6

172.46

Purchase

100

174.87

Purchase

50

174.32

Purchase

50

174.32

Purchase

100

174.27

Purchase

100

174.85

Purchase

15

174.17

Purchase

100

174.28

Purchase

100

174.59

Purchase

100

174.71

Purchase

100

175.38

Purchase

100

173.23

Purchase

193

174.367098

Purchase

22

172.86

Purchase

6,139

173

Purchase

100

174.34

Purchase

100

175.61

Purchase

100

175.49

Purchase

100

175.19

Purchase

1

174.94

Purchase

100

175.11

Purchase

100

174.87

Purchase

100

173.36

Purchase

100

174.92

Purchase

100

175.48

Purchase

100

174.82

Purchase

65

173

Purchase

22

173

Purchase

1

173

Purchase

100

173

Purchase

750

173

Purchase

79

173.195

Purchase

6

173

Purchase

200

173

Purchase

721

173

Purchase

1,489

173

Purchase

651

173

Purchase

222

173

Purchase

1,457

173

Purchase

1

173

Purchase

49

173

Purchase

60

174.54

Purchase

40

174.54

Purchase

100

175.03

Purchase

100

174.55

Purchase

89

174.81

Purchase

11

174.81

Purchase

10

175.73

Purchase

50

175.72

Purchase

100

175.61

Purchase

100

175.59

Purchase

40

175.72

Purchase

100

174.47

Purchase

1

175.06

Purchase

99

175.06

Purchase

200

174.88

Purchase

100

174.79

Purchase

50

175.22

Purchase

50

175.22

Purchase

100

176.31

Purchase

1

175.45

Purchase

50

175.02

Purchase

50

175.02

Purchase

100

175.1

Purchase

100

175.23

Purchase

100

175.16

Purchase

100

176.28

Purchase

45

172.7

Purchase

100

174.61

Purchase

50

174.27

Purchase

50

175.99

Purchase

50

175.99

Purchase

48

175.09

Purchase

100

174.71

Purchase

100

174.41

Purchase

40

174.77

Purchase

50

174.77

Purchase

10

174.78

Purchase

99

175.34

Purchase

74

173.35

Purchase

100

174.97

Purchase

1

175.34

Purchase

45

174.46

Purchase

55

174.46

Purchase

100

174.42

Purchase

100

175.85

Purchase

100

175.92

Purchase

100

176.1

Purchase

100

174.54

Purchase

90

174.79

Purchase

10

174.79

Purchase

100

173.66

Purchase

75

174.49

Purchase

25

174.48

Purchase

72

174.3

Purchase

4

174.3

Purchase

11

174.3

Purchase

7

174.3

Purchase

6

174.3

Purchase

11

174.33

Purchase

89

174.33

Purchase

99

175.48

Purchase

1

175.48

Purchase

17

174.24

Purchase

16

176.31

Purchase

84

176.31

Purchase

100

173.36

Purchase

100

174.88

Purchase

100

174.8

Purchase

52

175.09

Purchase

17

175.19

Purchase

100

175.66

Purchase

100

174.37

Purchase

83

175.19

Purchase

83

176.11

Purchase

17

176.09

Purchase

100

175.4

Purchase

3

175.34

Purchase

86

175.34

Purchase

6

175.34

Purchase

5

175.34

Purchase

50

176.43

Purchase

50

176.43

Purchase

38

174.58

Purchase

29

173.08

Purchase

100

173.05

Purchase

6

173

Purchase

882

173

Purchase

5,516

173

Purchase

1,576

173

Purchase

500

173

Purchase

5,639

173

Sale

100

173.51

Sale

32

174.3

Sale

68

174.3

Sale

95

173.53

Sale

100

173.51

Sale

29

175.4

Sale

100

173.17

Sale

100

172.81

Sale

33

172.53

Sale

100

175.91

Sale

15

173.35

Sale

15

173.34

Sale

85

173.35

Sale

78

172.89

Sale

22

172.89

Sale

100

172.89

Sale

30

174.14

Sale

100

174.09

Sale

100

175.34

Sale

50

173.26

Sale

29

173.26

Sale

29

175.14

Sale

34

173.49

Sale

100

174.56

Sale

100

174.94

Sale

2,137

174.330412

Sale

20

173

Sale

5

173.53

Sale

104

175.248

Sale

100

174.5

Sale

100

174.91

Sale

50

174.43

Sale

100

174.29

Sale

50

174.43

Sale

50

172.42

Sale

100

172.41

Sale

18

172.42

Sale

99

174.79

Sale

35

172.81

Sale

35

172.76

Sale

29

175.33

Sale

29

175.1

Sale

100

173.4

Sale

99

173.41

Sale

1

173.54

Sale

65

175.33

Sale

693

170.96

Sale

1,258

174.188394

Sale

45

173

Sale

500

173

Sale

5,639

173

Sale

2,185

173.473657

Sale

210,000

170.13

Sale

594,341

170.13

Sale

50,808

170.13

Total Purchases

40,127

 

Total Sales

870,439

 

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit USD

(Note 5)

 

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)     Yes

 

Dateofdisclosure

30/03/2020

Contact name

Société Générale - Disclosure team

Telephone number

+33 1 42 14 92 74

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

 

If aconnectedEFM,statenatureofconnection (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ap23

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL 

ACT,   1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2)

Type, e.g.American,Europeanetc.

Expiry date

Listed Put Option

Sale

40,000

175

American options

15/01/2021

Listed Put Option

Sale

18,500

190

American options

15/01/2021

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the  

Rules. If in doubt, consult the Panel.

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISESDISWSESSEID

a d v e r t i s e m e n t